drugset / Trial / NCT03276026

A Study to Compare Neostigmine vs Sugammadex in Length of PACU Stay in Patients Undergoing Sleeve Gastrectomy Surgery

NCT03276026

RandomizedParallel-groupDouble-blindTreatment

Summary

The investigators will track bariatric patients who received sugammadex versus neostigmine in the post anesthesia care unit until discharge and assess their length of stay and possible nausea / vomiting / hypoxia episodes.

Timeline

Start
2018-02-12
Primary completion
2018-11-08
Completion
2018-11-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Neostigmine Other / unclassified 5 mg
Comparator Sugammadex Other / unclassified 2 mg/kg
Comparator Sugammadex Other / unclassified 4 mg/kg